Financial Shenanigans

The Forensic Verdict

Partners Group's reported earnings broadly track economic reality, but the forensic risk has stepped up materially in the last 12 months. Three things drive that: an active short campaign by Grizzly Research on 30 April 2026 alleging that close to 40% of the Master Fund's Western European holdings are mismarked, an auditor change at the May 2025 AGM (KPMG to PwC after a 2022-initiated tender), and a 41% jump in receivables in FY2024 against single-digit revenue growth that resolved only as performance fees printed in FY2025. None of these is a confirmed misstatement, but together they make the private valuation discipline that supports CHF 819M of FY2025 performance fees the load-bearing forensic question. Three years of CFO/NI of 0.91 and FCF/NI of 0.85 indicate adequate cash conversion, and the conservative "lower-of" performance-fee recognition framework (50% NAV stress, claw-back, 40% employee profit-share) is the cleanest offsetting evidence. The single data point that would most change the grade: a clean PwC FY2025 audit opinion with no emphasis-of-matter on private investment fair values.

Shenanigans scorecard — all 13 categories

Breeding Ground

The breeding ground is moderate, not friendly: incentive design and audit oversight are reasonable, but private-asset dependence and an active short campaign raise the latent risk of an accounting flashpoint.

The auditor handover is the cleanest single governance event to flag. Lead auditor Philipp Rickert was due for the seven-year rotation regardless, the tender was opened in 2022, and PwC's audit fees came in identical to KPMG's. That is the textbook benign rotation. What raises the bar is timing — PwC inherits an audit cycle in which Master Fund private-asset valuations will draw forensic attention from external parties for the first time in over a decade. The Risk & Audit Committee held five meetings in 2025 with both KPMG and PwC participating in two of them; a clean PwC opinion on FY2025 (filed 10 March 2026 on the FY2024 cycle) and a clean opinion on FY2025 audited under PwC will be load-bearing.

Earnings Quality

Reported earnings reconcile reasonably to fundamentals, but the FY2024 receivables build, the FY2025 performance-fee surge, and the dependence on private-asset fair-value marks together create three judgment areas that deserve direct testing.

The FY2024 anomaly is real: receivables grew 41% on revenue of +9.8%. By 31 December 2024, CHF 1,155M of receivables sat against CHF 2,136M of revenue — a DSO of 197 days. The FY2025 print resolved it: receivables nudged down to CHF 1,135M while revenue rose 20% to CHF 2,563M, dragging DSO back to 162 days. Two mechanics explain it. First, performance fees recognized late in FY2024 (perf fees up 39% YoY) often invoice and collect months after recognition. Second, short-term treasury loans to client funds (CHF 1,634M at end-FY2024 vs CHF 1,657M at end-FY2025) flow through receivables-adjacent buckets. Neither mechanic looks like aggressive top-line acceleration, but both make receivables a less-clean tracking variable than for traditional fee-only managers.

Performance-fee dependence has stepped from 19% to 32% of revenues in two years. Management's published model is conservative — performance fees on closed-ended programs are recognized as the lower of (1) realized-investment fees and (2) realized-plus-stress-tested-NAV fees, with stress at 50% of NAV (up to 100% in select cases). On open-ended evergreens, fees use the high-water-mark mechanism on quarterly NAV development. That framework is cleaner than peers that book carry on a "1A" full mark-to-NAV approach. The risk is not the framework but the input — the NAV applied to step 2 — which is exactly where the Grizzly allegation lives.

EBITDA margin has held in a 1.7-point band for five years. Management explains it via fixed cost-income targets (40% on new management fees) and the mechanical 40% performance-fee comp share. That is a credible operating story. The forensic question is whether the band masks underlying lumpiness — and the answer is partially yes: the floor is held by performance-fee revenue plus the matched performance-fee comp accrual, both of which key off the same NAV inputs.

Cash Flow Quality

Year-by-year operating cash flow is volatile, but a multi-year average shows reasonable conversion. The biggest sensitivity is working capital — specifically the swing in receivables and the gross flows in client treasury loans — and the share of FY2025 CFO recovery that is genuinely durable versus a reversal of FY2023-FY2024 working-capital pressure.

The single-year CFO/NI ranges from 0.37 (FY2018) to 1.43 (FY2020). Annual cash-flow grades on this stock alone are misleading; the multi-year frame is the only honest one. Three-year FY2023-FY2025 totals: CHF 3,392M of net income, CHF 3,092M of CFO, CHF 2,867M of FCF — ratios of 0.91 and 0.85 respectively. After acquisitions of CHF 109M, three-year FCF after acquisitions runs CHF 2,758M, just over 81% of net income. That is acceptable for a private-markets manager but it is not the textbook 1.0+ that pure management-fee asset managers print.

The CHF -550M working-capital drag in FY2018 and CHF -857M drag in FY2021 are the two clearest signals that operating-cash-flow timing on this business cannot be assumed to follow earnings. The recovery in FY2025 (+CHF 122M) reverses two prior years of build-up; absent that swing, FY2025 CFO would have been roughly CHF 1,393M, putting CFO/NI closer to 1.10 — still healthy, but two-thirds of the headline 1.20 is normalisation not new operating power. That reading frames the Empira-acquired CFO uplift more conservatively too.

The CHF 2.0B reversal in net debt from FY2021 to FY2025 is the consequence of CHF 4.6B of dividends and CHF 1.5B of buybacks against CHF 2.7B of FCF over the same five years. The shortfall has been funded with CHF 1.5B of corporate bonds and rising credit-facility utilisation (CHF 1,056M drawn at end-FY2025 against a CHF 2,791M facility). Management's APM "Total net debt" of CHF 400M nets short-term loans to clients (CHF 1,657M) against gross debt — that netting is mechanically correct under their treasury-management model but worth flagging because it creates a CHF ~1.7B gap between APM net debt and a literal IFRS read.

Metric Hygiene

Disclosure quality is high by Swiss-listed asset-manager standards, but management-introduced metrics consistently frame the business toward stability. Three definition shifts in 24 months are worth tracking.

The single metric definition that matters most is the dropped redemption disclosure. Per Financial Times reporting (April 2026), withdrawal requests at the flagship US evergreen private equity fund hit USD 750M in Q3 2025 — double the same quarter a year earlier — and the fund entered net redemptions for the first time in 2024. Partners Group has publicly said it would impose limits on investor withdrawals if redemptions rise sharply. Pulling redemption inflow/outflow netting out of guidance just as the headline line is deteriorating is the textbook disclosure pattern that a forensic reader is trained to flag.

What to Underwrite Next

Five concrete diligence items, in order of materiality:

The accounting risk on PGHN sits between a footnote and a position-sizing limiter. Three-year cash conversion is acceptable, the performance-fee recognition framework is conservative, the auditor change is procedurally normal, and the breeding ground is constrained by multi-jurisdiction regulation. What is not yet known — and only the next two reporting cycles can answer — is whether the externally challenged private-asset marks survive closer scrutiny, whether evergreen redemption pressure forces gating that dents fee revenue, and whether the FY2025 working-capital tailwind reverses. Until those three clear, the appropriate underwriting stance is a 10-15% valuation reserve relative to a clean private-markets manager comp, the 95% dividend payout treated as informationally tight rather than safe, and FY2025 CFO/NI of 1.20 not assumed as a new run rate.